Andy Neely is Cambridge’s Pro-Vice-Chancellor for Enterprise and Business Relations, a role which oversees the University’s activities in innovation, commercialisation and entrepreneurship. After six months in the role, he sees an entrepreneurial ecosystem that may appear complex at first – but a deeper examination reveals a combination of knowledge, expertise, support and infrastructure that makes Cambridge one of the most enterprising and entrepreneurial cities in the world.
Cambridge-based start-up company Bicycle Therapeutics has recently raised £40 million from a range of investors to bring its cancer drug candidates to clinical trials.
A University of Cambridge spin-out company has raised £7 million in new funding, which will help in the development of treatments for liver and lung disease.
The University invested £2.7 million last year to support the development of Cambridge spin-outs.
Cambridge Innovation Capital announces first three investments from its £50 million Cambridge Cluster fund12 Aug 2014
Cambridge Innovation Capital (CIC), an investor in high-growth technology companies in the Cambridge cluster, has completed its first investments from a £50 million fund, backing three companies in the areas of cloud-based video archiving, grid-scale energy management and generative music composition.
A new £50 million investment business has been launched to support the development of University spin-outs and other early-stage technology companies in the Cambridge Cluster.